BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33966029)

  • 1. HPV vaccination to prevent recurrence of anal intraepithelial neoplasia in HIV+ MSM.
    Gosens KCM; van der Zee RP; van Heukelom MLS; Jongen VW; Cairo I; van Eeden A; van Noesel CJM; Quint WGV; Pasmans H; Dijkgraaf MGW; de Vries HJC; Prins JM
    AIDS; 2021 Sep; 35(11):1753-1764. PubMed ID: 33966029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effectiveness and cost-effectiveness of quadrivalent human papillomavirus vaccination in HIV-negative men who have sex with men to prevent recurrent high-grade anal intraepithelial neoplasia.
    Deshmukh AA; Chiao EY; Das P; Cantor SB
    Vaccine; 2014 Dec; 32(51):6941-6947. PubMed ID: 25444820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study.
    Swedish KA; Factor SH; Goldstone SE
    Clin Infect Dis; 2012 Apr; 54(7):891-8. PubMed ID: 22291111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcomes of Adding HPV Vaccine to the Anal Intraepithelial Neoplasia Treatment Regimen in HIV-Positive Men Who Have Sex With Men.
    Deshmukh AA; Chhatwal J; Chiao EY; Nyitray AG; Das P; Cantor SB
    Clin Infect Dis; 2015 Nov; 61(10):1527-35. PubMed ID: 26223993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of the Quadrivalent HPV Vaccine in Preventing Anal ≥ HSILs in a Spanish Population of HIV+ MSM Aged > 26 Years.
    Hidalgo-Tenorio C; Pasquau J; Omar-Mohamed M; Sampedro A; López-Ruz MA; López Hidalgo J; Ramírez-Taboada J
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33498165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Methylation Analysis to predict Regression of high-grade anal Intraepithelial Neoplasia in HIV+ men (MARINE): a cohort study protocol.
    Dias Gonçalves Lima F; van der Zee RP; Dick S; van Noesel CJM; Berkhof J; Schim van der Loeff MF; Prins JM; Steenbergen RDM; de Vries HJC
    BMJ Open; 2022 Aug; 12(8):e060301. PubMed ID: 35922105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.
    Goldstone SE; Giuliano AR; Palefsky JM; Lazcano-Ponce E; Penny ME; Cabello RE; Moreira ED; Baraldi E; Jessen H; Ferenczy A; Kurman R; Ronnett BM; Stoler MH; Bautista O; Das R; Group T; Luxembourg A; Zhou HJ; Saah A
    Lancet Infect Dis; 2022 Mar; 22(3):413-425. PubMed ID: 34780705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors of high-grade anal intraepithelial neoplasia recurrence in HIV-infected MSM.
    Burgos J; Curran A; Landolfi S; Guelar A; Miguel L; Dinares M; Villar J; Navarro J; Hernandez-Losa J; Falcó V
    AIDS; 2017 Jun; 31(9):1245-1252. PubMed ID: 28252530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus.
    Palefsky JM; Lensing SY; Belzer M; Lee J; Gaur AH; Mayer K; Futterman D; Stier EA; Paul ME; Chiao EY; Reirden D; Goldstone SE; Tirado M; Cachay ER; Barroso LF; Da Costa M; Darragh TM; Rudy BJ; Wilson CM; Kahn JA
    Clin Infect Dis; 2021 Oct; 73(8):1388-1396. PubMed ID: 33991185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of High-Grade Anal Intraepithelial Neoplasia in HIV+ Men.
    Gosens KCM; van der Burg SH; Welters MJP; Boekestijn S; Loof NM; Quint WGV; van Noesel CJM; van der Wal AC; Richel O; Krebber WJTA; Melief CJM; de Vries HJC; Prins JM
    Clin Cancer Res; 2023 Oct; 29(20):4109-4117. PubMed ID: 37540563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM).
    Hidalgo-Tenorio C; Ramírez-Taboada J; Gil-Anguita C; Esquivias J; Omar-Mohamed-Balgahata M; SamPedro A; Lopez-Ruz M; Pasquau J
    AIDS Res Ther; 2017 Jul; 14(1):34. PubMed ID: 28720147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant HPV vaccination for anal cancer prevention in HIV-positive men who have sex with men: The time is now.
    Deshmukh AA; Cantor SB; Fenwick E; Chiao EY; Nyitray AG; Stier EA; Goldstone SE; Wilkin T; Chhatwal J
    Vaccine; 2017 Sep; 35(38):5102-5109. PubMed ID: 28807605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of oncogenic human papillomavirus determination for diagnosis of high-grade anal intraepithelial neoplasia in HIV-infected MSM.
    Burgos J; Hernández-Losa J; Landolfi S; Guelar A; Dinares M; Villar J; Navarro J; Ribera E; Falcó V; Curran A
    AIDS; 2017 Oct; 31(16):2227-2233. PubMed ID: 28723712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection With Chlamydia trachomatis Increases the Risk of High-grade Anal Intraepithelial Neoplasia in People Living With Human Immunodeficiency Virus.
    Masiá M; Fernández-González M; García JA; Padilla S; García-Payá E; Gutiérrez A; Ortiz de la Tabla V; García-Abellán J; Agulló V; Gutiérrez F
    Clin Infect Dis; 2020 May; 70(10):2161-2167. PubMed ID: 31271192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV and anal cancer in HIV-infected individuals: a review.
    Schim van der Loeff MF; Mooij SH; Richel O; de Vries HJ; Prins JM
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):250-62. PubMed ID: 24990810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence and incidence of high-grade anal intraepithelial neoplasia among young Thai men who have sex with men with and without HIV.
    Phanuphak N; Teeratakulpisarn N; Triratanachat S; Keelawat S; Pankam T; Kerr SJ; Deesua A; Tantbirojn P; Numto S; Phanuphak P; Palefsky JM; Ananworanich J
    AIDS; 2013 Jul; 27(11):1753-62. PubMed ID: 23807271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-grade anal intraepithelial neoplasia among HIV-1-infected men screening for a multicenter clinical trial of a human papillomavirus vaccine.
    Wilkin T; Lee JY; Lensing SY; Stier EA; Goldstone SE; Berry MJ; Jay N; Aboulafia DM; Einstein MH; Saah A; Mitsuyasu RT; Palefsky JM
    HIV Clin Trials; 2013; 14(2):75-9. PubMed ID: 23611828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of precancerous anal intraepithelial lesions in human immunodeficiency virus-positive men who have sex with men: Clinical effectiveness and cost-effectiveness.
    Deshmukh AA; Chiao EY; Cantor SB; Stier EA; Goldstone SE; Nyitray AG; Wilkin T; Wang X; Chhatwal J
    Cancer; 2017 Dec; 123(23):4709-4719. PubMed ID: 28950043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of electrocautery ablation for the treatment of high-grade anal intraepithelial neoplasia in HIV-infected men who have sex with men.
    Burgos J; Curran A; Landolfi S; Navarro J; Tallada N; Guelar A; Crespo M; Ocaña I; Ribera E; Falcó V
    HIV Med; 2016 Aug; 17(7):524-31. PubMed ID: 26688291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia.
    Palefsky JM; Giuliano AR; Goldstone S; Moreira ED; Aranda C; Jessen H; Hillman R; Ferris D; Coutlee F; Stoler MH; Marshall JB; Radley D; Vuocolo S; Haupt RM; Guris D; Garner EI
    N Engl J Med; 2011 Oct; 365(17):1576-85. PubMed ID: 22029979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.